This study investigated the effect of electroacupuncture (EA) on high-salt-induced vascular dysfunction. EA reversed vascular damage and gut dysbiosis, possibly by modulating specific gut microbes.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Research Article
* These authors contributed equally
This study investigated the effect of electroacupuncture (EA) on high-salt-induced vascular dysfunction. EA reversed vascular damage and gut dysbiosis, possibly by modulating specific gut microbes.
This study aims to investigate the therapeutic potential and mechanisms of electroacupuncture (EA) in alleviating vascular dysfunction caused by high-salt diets, with a focus on gut microbiota modulation. We randomly divided 21 rats into Normal Control, High-Salt Model, and EA Intervention groups (n = 7 per group). The "high-salt blood stasis syndrome" model in Wistar rats was induced by intragastric perfusion of 12% NaCl. Treatments were performed between 17:00 and 19:00 Beijing time: rats were restrained with a soft cloth, followed by 20-min EA stimulation at BL23 and KI3. After the experiment, rat blood, blood vessels, and fecal samples were collected. Vascular effects were evaluated via coagulation function test, hemorheological analysis, and arterial histopathological assessment. 16S rDNA sequencing was used to analyze the composition and abundance changes of gut microbiota. The findings revealed that chronic high-salt intake disrupted blood viscosity, damaged vascular endothelial integrity, and caused gut microbial dysbiosis. Remarkably, EA treatment effectively reversed these pathological changes. Correlation analysis further identified specific gut microbiota (e.g., Lachnospiraceae and Ruminococcaceae) that strongly correlated with altered blood viscosity parameters (P < 0.05). Therefore, the present study concludes that high-salt diet-induced vasculopathy can be reversed by EA treatment, which may be attributed to EA's ability to regulate gut microbiota involved in bile acid metabolism and short-chain fatty acid synthesis.
Dietary salt plays a crucial role in maintaining fluid balance and cellular homeostasis, yet excessive consumption represents a well-established risk factor for cardiovascular and cerebrovascular disease1. The World Health Organization recommends limiting daily sodium intake to less than 5 grams for healthy adults2. Research has demonstrated that a high salt diet (HSD) impairs vascular function and that cardiovascular disease (CVD), the most prevalent disease in the world, is often accompanied by vasculopathy3. These findings underscore that repairing vascular endothelial damage caused by HSD cons....
Access restricted. Please log in or start a trial to view this content.
The entire experiment was conducted at the Experimental Center of the Basic Medical School of Chengdu University of Traditional Chinese Medicine. All animal welfare and experimental procedures were approved by the Laboratory Animal Welfare Ethics Committee of Chengdu University of Traditional Chinese Medicine (Ethics No. 2024078). Experiments were performed strictly following the NIH Guide for the Care and Use of Laboratory Animals (1986 revision, Publication 86-23).
Animals and diet
Male and female specific pathogen-free (SPF) Wistar rats, aged 6-8 weeks, weighed 200 ± 20 g. All rats were housed in well-ventilated room....
Access restricted. Please log in or start a trial to view this content.
Validation of the animal model
The four coagulation parameters play a pivotal role in vascular lesion research by monitoring coagulation function abnormalities closely linked to vascular pathological changes. Post-modeling evaluation of retro-orbital venous plexus blood demonstrated significant alterations in coagulation parameters (PT, APTT, FIB, TT) between HS/EA groups versus NC controls (Figure 3). Specific test values are provided in Supplementary Table 1
Access restricted. Please log in or start a trial to view this content.
Vascular lesions are a critical factor in the development and pathological manifestations of various CVD and metabolic disorders. Their detrimental effects include vascular dysfunction, abnormal blood clotting, lipid deposition, and plaque formation, which can lead to elevated blood pressure, thrombosis, and arterial plaque development, ultimately resulting in various CVD14,15,16. Therefore, timely intervention to halt the progr.......
Access restricted. Please log in or start a trial to view this content.
The authors declare no conflicts of interest.
This research was funded by the Sichuan Provincial Department of Science and Technology (Grant No. 2024NSFSC0717). Thanks to Figdraw for the assistance provided in figure preparation.
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| Acupuncture needles | Suzhou Medical Supplies Factory Co., Ltd. | 242059 | 0.18 × 13 mm |
| Activated Partial Thromboplastin Time (APTT) Assay Kit (Clotting Method) | Beijing Succeeder Technology Inc. | R21D24C4 | |
| AMPure XP beads | Beckman Coulter Genomics | A63881 | |
| Automatic Coagulation Analyzer | Beijing Succeeder Technology Inc. | SF-8050 | |
| Fibrinogen (FIB) Assay Kit (Clotting Method) | Beijing Succeeder Technology Inc. | R31D24D2 | |
| Fully Automatic Blood Rheology Tester | Beijing Succeeder Technology Inc. | SA-5600 | |
| GraphPad Prism 10 | GraphPad Software, Inc. | ||
| H&E staining solution | Wuhan Saiweier Biotechnology Co., Ltd | G1005 | |
| Illumina library quantification kit | Kapa Biosciences | 7960166001 | |
| Isoflurane | RWD Life Science | R510-22-10 | 100 mL |
| Magnetic bead-based stool genomic DNA extraction kit | Biotek | AU46111-96 | |
| Nikon Eclipse Ci-L upright white light microscope | Nikon | ||
| QIIME 2 | https://qiime2.org/ | ||
| SDZ-II Huatuo electronic acupuncture device | Suzhou Medical Supplies Factory Co., Ltd. | SDZ-II | |
| SILVA database | Release 138, https://www.arb-silva.de/ | ||
| Sodium chloride | Chengdu Jinshan Chemical Reagents Co., Ltd. | 20231008 | 500 g |
| SPF Wistar rats | SPF (Beijing) Biotechnology Co., Ltd. | SCXK (Beijing) 2024-0001 | |
| Thrombin Time (TT) Assay Kit (Clotting Method) | Beijing Succeeder Technology Inc. | R4D24E1 |
Access restricted. Please log in or start a trial to view this content.